📖 Approx. 3 minutes ／ Updated 2026.06.17
In this article, a medical industry-specialized M&A advisor will explain from a practical perspective what issues arise when becoming a Specific Medical Corporation in business succession and medical M&A within aesthetic medicine. We will provide concrete countermeasures based on self-pay medical revenue, equipment renewal cycles, tax incentives, and public interest requirements.
1. Industry Background of Specific Medical Corporation Conversion in Aesthetic Medicine
According to the Ministry of Health, Labour and Welfare’s Survey of Medical Institutions, the management environment for medical institutions, including aesthetic medicine, has become increasingly severe in recent years due to complex factors such as medical fee revisions, rising personnel costs, and the burden of equipment investment. Particularly from the perspective of self-pay medical revenue and equipment renewal cycles, interest in third-party succession M&A is growing.
At the same time, becoming a Specific Medical Corporation is an important issue in medical M&A practice. By appropriately designing tax incentives and public interest requirements, a succession that benefits both the transferor and the transferee can be achieved.
2. Key Practical Points
- Preparation: Organize the unique operational flow, patient base, and equipment status specific to aesthetic medicine, and clarify the transfer conditions.
- Business Valuation: Calculate an appropriate transfer price range based on the characteristics of the medical specialty. In aesthetic medicine, self-pay medical revenue and equipment renewal cycles are key to valuation.
- Specific Medical Corporation Conversion Design: Select the optimal scheme based on tax incentives and public interest requirements. Verification from tax, legal, and labor perspectives is also necessary.
- Partner Search & Matching: Select potential transferees suitable for the medical specialty from a nationwide network. Carefully proceed with aligning desired conditions.
- Due Diligence: Conduct thorough investigations from financial, legal, labor, and medical practice perspectives. Also confirm permits, licenses, and facility standards specific to aesthetic medicine.
- Final Agreement & Closing: Conclude the final agreement, including representations and warranties, and indemnity clauses. Proceed with permit/license transfer and staff notification in parallel.
3. Specific Considerations in Aesthetic Medicine
In M&A of medical institutions in aesthetic medicine, self-pay medical revenue and equipment renewal cycles hold the key to successful succession. Numerous individual issues exist depending on the characteristics of the medical specialty, such as patient base continuity, employment retention of staff (doctors, nurses, allied health professionals), equipment status and renewal plans, and maintenance/acquisition of facility standards.
Furthermore, strategic design based on market characteristics unique to aesthetic medicine, such as the composition of insured and self-pay medical services, the status of regional medical collaboration, and relationships with nearby competing medical institutions, is important. Leveraging our track record in supporting aesthetic medicine succession, we provide practical support from an industry-specific perspective.
4. Practical Details of Specific Medical Corporation Conversion
Becoming a Specific Medical Corporation is an area that requires specialized consideration in medical M&A. Designing based on tax incentives and public interest requirements is key to success.
- Confirmation of Related Laws and Practical Standards: Development based on Medical Act, Tax Law, and Labor Laws.
- Collaboration with Professionals: Collaboration with certified public accountants, tax accountants, lawyers, and labor and social security attorneys.
- Risk Assessment: Identification of potential risks and formulation of countermeasures.
- Consensus Building Between Parties: Designing conditions that are satisfactory to both the transferor and the transferee.
- Proper Documentation: Clear specification in the basic agreement and final contract.
Frequently Asked Questions
Q. What documents are required for consultation?
A. It would be smooth if you could prepare financial statements for the last three fiscal years, patient trend data, staff composition, equipment list, and lease agreements (if applicable) in advance. We will receive them after an NDA is signed.
Q. What is the market price range for aesthetic medicine transfers?
A. In aesthetic medicine, self-pay medical revenue and equipment renewal cycles are the valuation axes. For clinics without beds, it’s typically 0.5 to 1.5 times annual revenue, and for hospitals with beds, EBITDA multiples of 3 to 7 times are a guideline. We will provide details in a free preliminary assessment.
Q. What are the precautions when proceeding with Specific Medical Corporation conversion?
A. Prior design based on tax incentives and public interest requirements is essential. Seamless practical execution through collaboration with professionals is key to success.
Q. Will staff and patients know about the consultation?
A. Information disclosure is limited to after an NDA is signed, and no disclosure to stakeholders will be made before the final agreement. We thoroughly ensure confidentiality.
Related Columns
- Complete Guide to Hospital and Medical Corporation Business Succession | Medical M&A Practices from Successor Shortage to Success Stories
- Complete Guide to Clinic Sale/Transfer | Medical M&A Experts Explain Price Trends, Process, and Considerations
- How to Proceed with Medical M&A and Hospital Succession | 6 Steps from Consultation to Agreement Explained with Examples
- Complete Guide to Medical Corporation M&A Tax Schemes | Key Issues for Tax Accountants and Certified Public Accountants
For consultations on Specific Medical Corporation Conversion in Aesthetic Medicine, contact M&A Medical.
Strict Confidentiality – Free Initial Consultation – Success Fee Basis